STOCK PURCHASE AGREEMENT BY AND AMONG BLUEBIRD BIO, INC., PRECISION GENOME ENGINEERING, INC., DR. ANDREW SCHARENBERG, M.D., AS REPRESENTATIVE, AND THE OTHER PERSONS LISTED ON THE SIGNATURE PAGES HERETO DATED AS OF JUNE 30, 2014Stock Purchase Agreement • June 30th, 2014 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJune 30th, 2014 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of June 30, 2014, by and among Precision Genome Engineering, Inc., a Washington corporation (the “Company”), Dr. Andrew Scharenberg, M.D., as Representative (as further described in Section 9.7), each of the stockholders and Optionholders (as defined below) of the Company listed on the signature pages hereto (each such stockholder and Optionholder, an “Equityholder,” and collectively, the “Equityholders”), and bluebird bio, Inc., a Delaware corporation (“Buyer”). The Company, the Equityholders, the Representative and Buyer are collectively referred to herein as the “Parties” and each individually as a “Party.” Capitalized terms used in this Agreement without definition shall have the meaning given to such terms in ARTICLE I hereof.